Hutton Collins invests in James Hull Associates

Hutton Collins is pleased to announce its investment in James Hull Associates (“JHA”), the market leader in premium specialist and cosmetic dental treatment in the UK.  Hutton Collins invested alongside the founder and Chairman, James Hull, who was looking for a partner to assist with the future growth and acquisition-led expansion of the business.

Hutton Collins made a preferred equity investment and acquired a substantial minority equity stake in the business.  In order to expedite the transaction process, Hutton Collins also underwrote the senior facilities, which are currently being syndicated.

Founded in 1987, JHA operates 34 dental practices across the UK.  The Group, through its leading specialist and cosmetic dental surgeons, is a centre of clinical excellence for a range of dental treatments, including dental implants, complex bridgework and teeth whitening.  In addition the Group has recently expanded its services to offer non-invasive cosmetic surgery procedures (Botox and dermal fillers) at a number of its clinics.

James Hull of JHA commented:

“The Company is proud of its achievements to-date, and we now look forward to an exciting phase of strong growth. We believe that we have an excellent product offering, which is delivered via an exceptional workforce of highly skilled general and specialist dentists. Having successfully brought in a new investor, we will now be able to make our offering more accessible to other patients, as we expand further in the UK and increase the range of treatments we provide. We are delighted to have identified a supportive investor in Hutton Collins, who share our ambition and vision. Both I and our dentists are looking forward to working with our new partner to drive the business forward.”

Graham Hutton of Hutton Collins commented:

“We are delighted to have had the opportunity to make a major investment in James Hull Associates.  This is our largest investment to date, a fact which reflects our confidence in this excellent company which provides a first class level of service to its customers and benefits from a dedicated and professional workforce and dynamic management.  We are committed to funding the high levels of growth which we anticipate from this investment and look forward to working with Dr Hull and his team.”